<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03523988</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00001679</org_study_id>
    <nct_id>NCT03523988</nct_id>
  </id_info>
  <brief_title>Pre-emptive Analgesics in Orthodontic Treatment</brief_title>
  <official_title>Effects of Pre-emptive Use of Combined Ibuprofen and Acetaminophen on Pain Control in Orthodontic Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to determine if the preemptive use of a combination of acetaminophen
      and ibuprofen is more effective in reducing pain following orthodontic tooth movement when
      compared to the use of acetaminophen and ibuprofen alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is designed to determine if the preemptive use of a combination of acetaminophen
      and ibuprofen is more effective in reducing pain following orthodontic tooth movement when
      compared to the use of acetaminophen and ibuprofen alone. Before their orthodontic
      appointment, participants will be administered acetaminophen (650mg), ibuprofen (400mg), or
      acetaminophen (650mg) + ibuprofen (400mg). Participants will be asked to record their pain
      intensity using a numerical (0-10) visual analog scale (VAS) during rest, light biting, and
      while chewing paraffin wax during the following time intervals: immediately following drug
      administration, 6 hours after, the morning after, and the second morning after orthodontic
      treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2, 2017</start_date>
  <completion_date type="Actual">August 1, 2017</completion_date>
  <primary_completion_date type="Actual">June 23, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients of the University of Washington Graduate Orthodontics Clinic</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>The medications were prepared by the Kelley-Ross Compounding Group (Seattle, WA) and were identical in appearance. The bottles were labeled as &quot;A&quot;, &quot;B&quot;, or &quot;C&quot; and the identity of the medications were not revealed until after the data analysis was completed.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS) Pain Scores at 6 Hours After Treatment</measure>
    <time_frame>6 hours after orthodontic treatment</time_frame>
    <description>Pain scores were measured and recorded by selecting a number [0-10] using a visual analog scale to assess pain during the following actions: jaw at rest, lightly biting, and chewing paraffin wax.
The VAS consisted of a 10cm numerical scale from 0, representing &quot;no pain,&quot; to 10, representing &quot;worst possible, unbearable, excruciating pain.&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS) Pain Scores at 1 Day After Treatment</measure>
    <time_frame>1 day after orthodontic treatment</time_frame>
    <description>Pain scores were measured and recorded by selecting a number [0-10] using a visual analog scale to assess pain during the following actions: jaw at rest, lightly biting, and chewing paraffin wax.
The VAS consisted of a 10cm numerical scale from 0, representing &quot;no pain,&quot; to 10, representing &quot;worst possible, unbearable, excruciating pain.&quot;</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analog Scale (VAS) Pain Scores at 2 Days After Treatment</measure>
    <time_frame>2 days after orthodontic treatment</time_frame>
    <description>Pain scores were measured and recorded by selecting a number [0-10] using a visual analog scale to assess pain during the following actions: jaw at rest, lightly biting, and chewing paraffin wax.
The VAS consisted of a 10cm numerical scale from 0, representing &quot;no pain,&quot; to 10, representing &quot;worst possible, unbearable, excruciating pain.&quot;</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>NSAID</condition>
  <condition>Pain Management</condition>
  <arm_group>
    <arm_group_label>Acetaminophen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Acetaminophen 650mg powder in gel capsule taken by mouth before entering appointment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ibuprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetaminophen and Ibuprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acetaminophen 650mg and Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>Acetaminophen gel capsule</description>
    <arm_group_label>Acetaminophen</arm_group_label>
    <arm_group_label>Acetaminophen and Ibuprofen</arm_group_label>
    <other_name>Tylenol</other_name>
    <other_name>Paracetamol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>Ibuprofen gel capsule</description>
    <arm_group_label>Acetaminophen and Ibuprofen</arm_group_label>
    <arm_group_label>Ibuprofen</arm_group_label>
    <other_name>Advil</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -Orthodontic patient presenting for orthodontic treatment

        Exclusion Criteria:

          -  History of taking an analgesic in the past six hours

          -  Hypersensitivity to ibuprofen or acetaminophen

          -  Aspirin-sensitive asthma

          -  Renal or liver impairment

          -  History of GI bleeding or ulcers

          -  Cardiovascular disease, recent myocardial infarction, heart failure, or coronary
             artery bypass graft surgery

          -  Currently taking antibiotics or other medications for a chronic systemic disease

          -  Bleeding disorder

          -  Pregnant or nursing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne-Marie Bollen, DDS, MS, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>April 19, 2018</study_first_submitted>
  <study_first_submitted_qc>May 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2018</study_first_posted>
  <results_first_submitted>August 3, 2018</results_first_submitted>
  <results_first_submitted_qc>October 3, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">October 30, 2018</results_first_posted>
  <last_update_submitted>August 12, 2019</last_update_submitted>
  <last_update_submitted_qc>August 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Andrew Keith</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Pre-emptive analgesics</keyword>
  <keyword>Acetaminophen</keyword>
  <keyword>Ibuprofen</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 19, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/88/NCT03523988/Prot_003.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/88/NCT03523988/SAP_004.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 26, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/88/NCT03523988/ICF_005.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Orthodontic patients that presented to the University of Washington Graduate Orthodontics Clinic between May 2nd and June 23rd, 2017 were approached for recruitment.</recruitment_details>
      <pre_assignment_details>Participants were screened against a set of inclusion criteria during the informed consent process. If one or more of the inclusion were not met then the patient was not assigned to a group.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Acetaminophen</title>
          <description>Acetaminophen 650mg powder in gel capsule taken by mouth before entering appointment
Acetaminophen: Acetaminophen gel capsule</description>
        </group>
        <group group_id="P2">
          <title>Ibuprofen</title>
          <description>Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment
Ibuprofen: Ibuprofen gel capsule</description>
        </group>
        <group group_id="P3">
          <title>Acetaminophen and Ibuprofen</title>
          <description>Acetaminophen 650mg and Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment
Acetaminophen: Acetaminophen gel capsule
Ibuprofen: Ibuprofen gel capsule</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="7"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="16"/>
                <participants group_id="P3" count="18"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Acetaminophen</title>
          <description>Acetaminophen 650mg powder in gel capsule taken by mouth before entering appointment
Acetaminophen: Acetaminophen gel capsule</description>
        </group>
        <group group_id="B2">
          <title>Ibuprofen</title>
          <description>Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment
Ibuprofen: Ibuprofen gel capsule</description>
        </group>
        <group group_id="B3">
          <title>Acetaminophen and Ibuprofen</title>
          <description>Acetaminophen 650mg and Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment
Acetaminophen: Acetaminophen gel capsule
Ibuprofen: Ibuprofen gel capsule</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="7"/>
            <count group_id="B2" value="8"/>
            <count group_id="B3" value="7"/>
            <count group_id="B4" value="22"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="8"/>
                    <count group_id="B3" value="7"/>
                    <count group_id="B4" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21.7" spread="9.6"/>
                    <measurement group_id="B2" value="25.9" spread="18.0"/>
                    <measurement group_id="B3" value="21.4" spread="15.3"/>
                    <measurement group_id="B4" value="23.1" spread="14.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="8"/>
                    <count group_id="B3" value="7"/>
                    <count group_id="B4" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="7"/>
                    <count group_id="B2" value="8"/>
                    <count group_id="B3" value="7"/>
                    <count group_id="B4" value="22"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="7"/>
                    <measurement group_id="B4" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Analog Scale (VAS) Pain Scores at 6 Hours After Treatment</title>
        <description>Pain scores were measured and recorded by selecting a number [0-10] using a visual analog scale to assess pain during the following actions: jaw at rest, lightly biting, and chewing paraffin wax.
The VAS consisted of a 10cm numerical scale from 0, representing &quot;no pain,&quot; to 10, representing &quot;worst possible, unbearable, excruciating pain.&quot;</description>
        <time_frame>6 hours after orthodontic treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>Acetaminophen 650mg powder in gel capsule taken by mouth before entering appointment
Acetaminophen: Acetaminophen gel capsule</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen</title>
            <description>Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment
Ibuprofen: Ibuprofen gel capsule</description>
          </group>
          <group group_id="O3">
            <title>Acetaminophen and Ibuprofen</title>
            <description>Acetaminophen 650mg and Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment
Acetaminophen: Acetaminophen gel capsule
Ibuprofen: Ibuprofen gel capsule</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale (VAS) Pain Scores at 6 Hours After Treatment</title>
          <description>Pain scores were measured and recorded by selecting a number [0-10] using a visual analog scale to assess pain during the following actions: jaw at rest, lightly biting, and chewing paraffin wax.
The VAS consisted of a 10cm numerical scale from 0, representing &quot;no pain,&quot; to 10, representing &quot;worst possible, unbearable, excruciating pain.&quot;</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Rest</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.6" spread="0.8"/>
                    <measurement group_id="O2" value="2.6" spread="2.2"/>
                    <measurement group_id="O3" value="1.0" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Biting</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="1.4"/>
                    <measurement group_id="O2" value="2.9" spread="2.5"/>
                    <measurement group_id="O3" value="2.0" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chewing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="1.4"/>
                    <measurement group_id="O2" value="4.0" spread="3.1"/>
                    <measurement group_id="O3" value="3.1" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.04</p_value>
            <p_value_desc>P-value for pain scores among the three comparison groups with jaw at rest.</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.63</p_value>
            <p_value_desc>P-value for pain scores among the three comparison groups while lightly biting.</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.41</p_value>
            <p_value_desc>P-value for pain scores among the three comparison groups while chewing paraffin wax.</p_value_desc>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Analog Scale (VAS) Pain Scores at 1 Day After Treatment</title>
        <description>Pain scores were measured and recorded by selecting a number [0-10] using a visual analog scale to assess pain during the following actions: jaw at rest, lightly biting, and chewing paraffin wax.
The VAS consisted of a 10cm numerical scale from 0, representing &quot;no pain,&quot; to 10, representing &quot;worst possible, unbearable, excruciating pain.&quot;</description>
        <time_frame>1 day after orthodontic treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>Acetaminophen 650mg powder in gel capsule taken by mouth before entering appointment
Acetaminophen: Acetaminophen gel capsule</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen</title>
            <description>Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment
Ibuprofen: Ibuprofen gel capsule</description>
          </group>
          <group group_id="O3">
            <title>Acetaminophen and Ibuprofen</title>
            <description>Acetaminophen 650mg and Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment
Acetaminophen: Acetaminophen gel capsule
Ibuprofen: Ibuprofen gel capsule</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale (VAS) Pain Scores at 1 Day After Treatment</title>
          <description>Pain scores were measured and recorded by selecting a number [0-10] using a visual analog scale to assess pain during the following actions: jaw at rest, lightly biting, and chewing paraffin wax.
The VAS consisted of a 10cm numerical scale from 0, representing &quot;no pain,&quot; to 10, representing &quot;worst possible, unbearable, excruciating pain.&quot;</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Rest</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="2.5"/>
                    <measurement group_id="O2" value="2.0" spread="1.7"/>
                    <measurement group_id="O3" value="1.1" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Biting</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="2.5"/>
                    <measurement group_id="O2" value="2.5" spread="2.1"/>
                    <measurement group_id="O3" value="2.1" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chewing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.6" spread="2.8"/>
                    <measurement group_id="O2" value="3.9" spread="3.1"/>
                    <measurement group_id="O3" value="2.7" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.65</p_value>
            <p_value_desc>P-value for pain scores among the three comparison groups with jaw at rest.</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.82</p_value>
            <p_value_desc>P-value for pain scores among the three comparison groups while lightly biting.</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.69</p_value>
            <p_value_desc>P-value for pain scores among the three comparison groups while chewing paraffin wax.</p_value_desc>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Visual Analog Scale (VAS) Pain Scores at 2 Days After Treatment</title>
        <description>Pain scores were measured and recorded by selecting a number [0-10] using a visual analog scale to assess pain during the following actions: jaw at rest, lightly biting, and chewing paraffin wax.
The VAS consisted of a 10cm numerical scale from 0, representing &quot;no pain,&quot; to 10, representing &quot;worst possible, unbearable, excruciating pain.&quot;</description>
        <time_frame>2 days after orthodontic treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acetaminophen</title>
            <description>Acetaminophen 650mg powder in gel capsule taken by mouth before entering appointment
Acetaminophen: Acetaminophen gel capsule</description>
          </group>
          <group group_id="O2">
            <title>Ibuprofen</title>
            <description>Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment
Ibuprofen: Ibuprofen gel capsule</description>
          </group>
          <group group_id="O3">
            <title>Acetaminophen and Ibuprofen</title>
            <description>Acetaminophen 650mg and Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment
Acetaminophen: Acetaminophen gel capsule
Ibuprofen: Ibuprofen gel capsule</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale (VAS) Pain Scores at 2 Days After Treatment</title>
          <description>Pain scores were measured and recorded by selecting a number [0-10] using a visual analog scale to assess pain during the following actions: jaw at rest, lightly biting, and chewing paraffin wax.
The VAS consisted of a 10cm numerical scale from 0, representing &quot;no pain,&quot; to 10, representing &quot;worst possible, unbearable, excruciating pain.&quot;</description>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="8"/>
                <count group_id="O3" value="7"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Rest</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="2.6"/>
                    <measurement group_id="O2" value="1.4" spread="1.5"/>
                    <measurement group_id="O3" value="0.4" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Biting</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="2.9"/>
                    <measurement group_id="O2" value="2.3" spread="1.5"/>
                    <measurement group_id="O3" value="0.9" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chewing</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="2.9"/>
                    <measurement group_id="O2" value="3.1" spread="2.0"/>
                    <measurement group_id="O3" value="1.6" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.53</p_value>
            <p_value_desc>P-value for pain scores among the three comparison groups with jaw at rest.</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.31</p_value>
            <p_value_desc>P-value for pain scores among the three comparison groups while lightly biting.</p_value_desc>
            <method>ANOVA</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.37</p_value>
            <p_value_desc>P-value for pain scores among the three comparison groups while chewing paraffin wax.</p_value_desc>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Participants were given the contact information (phone and email) of the Lead Researcher to self-report any adverse events that occurred from the time they were administered their drug to the time of the last data entry (2 days following administration).</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Acetaminophen</title>
          <description>Acetaminophen 650mg powder in gel capsule taken by mouth before entering appointment
Acetaminophen: Acetaminophen gel capsule</description>
        </group>
        <group group_id="E2">
          <title>Ibuprofen</title>
          <description>Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment
Ibuprofen: Ibuprofen gel capsule</description>
        </group>
        <group group_id="E3">
          <title>Acetaminophen and Ibuprofen</title>
          <description>Acetaminophen 650mg and Ibuprofen 400mg powder in gel capsule taken by mouth before entering appointment
Acetaminophen: Acetaminophen gel capsule
Ibuprofen: Ibuprofen gel capsule</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Headache</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Low rate of participants returning results led to small number of participants analyzed.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Lead Investigator</name_or_title>
      <organization>University of Washington</organization>
      <phone>4254668544</phone>
      <email>akeith@uw.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

